Janssen drops the BACE as Alzheimer’s candidate joins fail list

Janssen drops the BACE as Alzheimer’s candidate joins fail list

Submitted by admin on May 18, 2018 - 12:09pm
Source: 
Fierce Biotech
News Tags: 
JNJ
Janssen
BACE inhibitors
atabacestat
Alzheimer's disease
Headline: 
Janssen drops the BACE as Alzheimer’s candidate joins fail list
snippet: 

Johnson & Johnson’s Janssen unit has joined the far-from-exclusive Alzheimer's disease failure club after deciding to terminate trials of its BACE inhibitor atabacestat.

Do Not Allow Advertisers to Use My Personal information